Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -4,858.65%-11.28B | 101.28%237M | -6,526.83%-18.45B | -66.04%287M | 765.35%845M | 81.54%-127M | -212.05%-688M | -58.06%614M | 144.18%1.46B | -166.91%-3.31B |
Net profit before non-cash adjustment | -46.82%4.56B | 168.38%8.57B | 27.86%3.19B | -26.07%2.5B | 4.74%3.38B | -17.93%3.23B | 28.72%3.93B | 19.62%3.05B | 19.92%2.55B | -9.33%2.13B |
Total adjustment of non-cash items | -323.88%-1.79B | 110.83%800M | -1,554.53%-7.39B | -81.28%508M | 468.97%2.71B | -85.68%477M | 27.23%3.33B | 40.60%2.62B | 150.50%1.86B | -168.80%-3.69B |
-Depreciation and amortization | -7.41%1.15B | 8.57%1.24B | -12.94%1.14B | -6.01%1.31B | 9.99%1.4B | 14.61%1.27B | 3.26%1.11B | -8.98%1.07B | 18.24%1.18B | 1.63%998M |
-Reversal of impairment losses recognized in profit and loss | -67.54%37M | -5.79%114M | -90.22%121M | --1.24B | ---- | --245M | ---- | ---- | 102.55%318M | -67.83%157M |
-Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 1.58%321M | -26.17%316M |
-Share of associates | ---- | ---- | -85.71%3M | -8.70%21M | 130.00%23M | -16.67%10M | 200.00%12M | -97.45%4M | --157M | ---- |
-Disposal profit | -205.56%-323M | 161.08%306M | 8.24%-501M | -118.12%-546M | 75,450.00%3.01B | -100.74%-4M | 382.29%542M | -100.00%-192M | -108.70%-96M | 79.28%-46M |
-Net exchange gains and losses | -358.33%-31M | --12M | --0 | --0 | 1,033.33%28M | -106.82%-3M | --44M | --0 | --24M | ---- |
-Pension and employee benefit expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -92.31%11M | 741.18%143M |
-Other non-cash items | -200.23%-2.62B | 89.28%-874M | -437.29%-8.16B | 13.21%-1.52B | -67.85%-1.75B | -164.16%-1.04B | -6.24%1.62B | 3,367.92%1.73B | 98.99%-53M | -243.34%-5.26B |
Changes in working capital | -53.77%-14.05B | 35.88%-9.14B | -423.63%-14.25B | 48.17%-2.72B | -37.00%-5.25B | 51.81%-3.83B | -57.15%-7.95B | -71.47%-5.06B | -68.05%-2.95B | 36.24%-1.76B |
-Change in receivables | -218.94%-15.32B | 59.72%-4.8B | -155.70%-11.93B | -6.61%-4.66B | 29.31%-4.38B | -35.81%-6.19B | 30.38%-4.56B | -106.89%-6.55B | 21.57%-3.16B | -32.61%-4.03B |
-Change in inventory | 213.88%4.26B | -104.71%-3.74B | -229.39%-1.83B | 220.27%1.41B | -154.68%-1.17B | 155.49%2.15B | ---3.87B | ---- | ---- | ---- |
-Change in payables | -203.25%-127M | 116.51%123M | -272.85%-745M | 124.48%431M | 3,100.00%192M | -97.92%6M | -57.58%288M | 1,195.16%679M | -376.92%-62M | -102.46%-13M |
-Provision for loans, leases and other losses | 293.75%252M | -73.88%64M | 218.18%245M | -12.50%77M | -51.91%88M | 210.17%183M | -59.86%59M | --147M | ---- | ---- |
-Changes in other current assets | -299.23%-3.11B | -15,680.00%-779M | -78.26%5M | 21.05%23M | -9.52%19M | -83.46%21M | -80.76%127M | 140.00%660M | -88.00%275M | 1,050.62%2.29B |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | 2.30%-723M | -10.94%-740M | 1.04%-667M | 4.40%-674M | 0.56%-705M | -1.72%-709M | 9.72%-697M | 16.00%-772M | 13.79%-919M | 21.73%-1.07B |
Interest received (cash flow from operating activities) | -38.30%58M | -22.31%94M | -3.20%121M | -13.79%125M | 8.21%145M | 47.25%134M | 16.67%91M | 18.18%78M | -12.00%66M | 5.63%75M |
Tax refund paid | -228.31%-2.92B | 0.11%-890M | 11.43%-891M | -2.55%-1.01B | -22.32%-981M | -33.00%-802M | -12.50%-603M | 43.99%-536M | -336.99%-957M | 4.37%-219M |
Other operating cash inflow (outflow) | 0 | 0 | 0 | 0.00%1M | 1M | 0 | -200.00%-1M | 0.00%1M | 1M | 0 |
Operating cash flow | -1,044.34%-14.87B | 93.47%-1.3B | -1,469.22%-19.88B | -82.30%-1.27B | 53.79%-695M | 20.76%-1.5B | -208.62%-1.9B | -78.26%-615M | 92.37%-345M | -231.82%-4.52B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---14M | ---- | ---- |
Net intangibles purchase and sale | 38.39%-69M | -761.54%-112M | -30.00%-13M | 83.61%-10M | 37.11%-61M | 50.00%-97M | 36.60%-194M | -287.34%-306M | -243.48%-79M | -27.78%-23M |
Net business purchase and sale | ---970M | --0 | ---- | ---- | ---- | 12.00%28M | --25M | ---- | ---- | ---- |
Net investment product transactions | -96.28%141M | 6,411.67%3.79B | -500.00%-60M | -97.10%15M | -18.58%517M | 172.41%635M | -1,352.86%-877M | -75.09%70M | -62.48%281M | 393.73%749M |
Net changes in other investments | 91.23%-5M | -612.50%-57M | -14.29%-8M | 53.33%-7M | 88.89%-15M | -236.36%-135M | -40.00%99M | 201.85%165M | 59.30%-162M | -342.22%-398M |
Investing cash flow | -124.96%-903M | 4,566.67%3.62B | -3,950.00%-81M | -100.45%-2M | 2.32%441M | 145.51%431M | -1,014.12%-947M | -312.50%-85M | -87.80%40M | -45.33%328M |
Financing cash flow | ||||||||||
Net issuance payments of debt | 2,524.46%15.86B | -103.15%-654M | 1,614.60%20.78B | -41.56%1.21B | 10.50%2.07B | 3,441.51%1.88B | -83.69%53M | -31.58%325M | 125.21%475M | 51.13%-1.88B |
Net common stock issuance | ---283M | --0 | ---- | ---- | ---- | ---- | ---- | --0 | --0 | ---776M |
Increase or decrease of lease financing | -2.84%-181M | -2.33%-176M | -2.38%-172M | 67.88%-168M | -98.86%-523M | ---263M | ---- | ---- | ---- | ---- |
Cash dividends paid | -25.74%-640M | -26.30%-509M | -9.81%-403M | -10.88%-367M | 12.66%-331M | -32.98%-379M | 19.72%-285M | -101.70%-355M | 4.35%-176M | 0.00%-184M |
Net other fund-raising expenses | -113.19%-24M | 1,111.11%182M | -50.00%-18M | -300.00%-12M | -250.00%-3M | -86.67%2M | 400.00%15M | -155.56%-5M | 325.00%9M | 50.00%-4M |
Financing cash flow | 1,372.95%14.73B | -105.73%-1.16B | 2,935.79%20.19B | -45.36%665M | -1.62%1.22B | 670.05%1.24B | -520.00%-217M | -111.36%-35M | 110.81%308M | 29.63%-2.85B |
Net cash flow | ||||||||||
Beginning cash position | 23.21%6.1B | 4.76%4.95B | -11.36%4.72B | 21.29%5.33B | 3.98%4.39B | -42.37%4.22B | -8.49%7.33B | 0.05%8.01B | -46.81%8.01B | -0.09%15.05B |
Current changes in cash | -189.50%-1.04B | 416.44%1.16B | 137.25%225M | -162.72%-604M | 487.20%963M | 105.36%164M | -316.60%-3.06B | -24,600.00%-735M | 100.04%3M | -46,860.00%-7.04B |
Effect of exchange rate changes | 358.33%31M | ---12M | --0 | --0 | -1,033.33%-28M | 107.14%3M | -173.68%-42M | --57M | --0 | ---- |
Cash adjustments other than cash changes | 150.00%1M | ---2M | ---- | ---1M | ---- | 150.00%1M | 0.00%-2M | -300.00%-2M | 200.00%1M | -200.00%-1M |
End cash Position | -16.54%5.09B | 23.21%6.1B | 4.76%4.95B | -11.36%4.72B | 21.29%5.33B | 3.98%4.39B | -42.37%4.22B | -8.49%7.33B | 0.05%8.01B | -46.81%8.01B |
Free cash flow | -958.40%-14.93B | 92.91%-1.41B | -1,457.95%-19.9B | -68.92%-1.28B | 52.78%-756M | 23.47%-1.6B | -123.74%-2.09B | -120.52%-935M | 90.68%-424M | -233.19%-4.55B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |